The effect of surgical volume and the provision of residency and fellowship training on complications of major hepatic resection.
BACKGROUND
Positive volume-outcomes relationships have been demonstrated for hepatic resection using arbitrary criteria to define high-volume centers. The safety of training programs has not been evaluated. The association of surgical volume, as a continuous variable and the influence of a surgical residency and a fellowship program on outcomes after major hepatectomy were determined.


METHODS
The Nationwide Inpatient Sample (NIS) was queried from 1998 to 2006. Quantification of patients' comorbidities was made using the Charlson index, and mortality, and complication rates were determined. Institutions' annual case volumes were correlated with risk-adjusted outcomes over time, as well as presence or absence of residency or fellowship training program using logistic regression modeling.


RESULTS
A total of 5,298 major hepatectomies were recorded, representing a weighted nationwide total of 26,396 cases. In-hospital unadjusted mortality for the study period was 6%. Adjusting for comorbidities, greater major hepatectomy volume was associated with improvements in the incidence of most measured complications, with plateauing of mortality of between 2% and 3% at approximately 50 cases per year. The mortality rate increased once greater than approximately 70 cases were performed per annum. Hospitals supporting a surgical residency program had lower overall morbidity and mortality. A fellowship program however was not associated with overall lower morbidity and mortality and appeared to result in a higher rate of certain complications.


CONCLUSIONS
Greater annual major hepatectomy volume improves outcomes with reduced mortality up to a certain point. The presence of surgical residency program but not a fellowship program is associated with reduced predicted morbidity and mortality.
Kohn
Geoffrey Paul
GP
Department of Surgery, Monash University, Maroondah Hospital, 1 Davey Drive Ringwood East, Victoria, 3135, Australia. gkohn@uppergi.net
Nikfarjam
Mehrdad
M
D005257:Fellowships and Scholarships; D006498:Hepatectomy / Q000009:adverse effects* / Q000193:education / Q000379:methods / Q000706:statistics & numerical data*; D006801:Humans; D007396:Internship and Residency; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality
Ann Surg Oncol. 2009 Jul;16(7):1860-7
19037703
Cancer Chemother Pharmacol. 1989;23 Suppl:S78-82
2538269
Ann Surg. 1983 Apr;197(4):375-88
6299217
Arch Surg. 1999 Sep;134(9):984-92
10487594
N Engl J Med. 2003 Nov 27;349(22):2117-27
14645640
J Gastrointest Surg. 2008 May;12(5):842-51
18266046
Arch Surg. 1995 Feb;130(2):198-203
7848092
Dis Esophagus. 2004;17(4):310-4
15569369
BMC Cancer. 2004 Dec 20;4:94
15610554
Cancer. 2006 Jun 1;106(11):2476-81
16634089
N Engl J Med. 2002 Apr 11;346(15):1128-37
11948273
J Gastrointest Surg. 2009 Nov;13(11):1900-10; discussion 1910-2
19760305
Chest. 2004 Oct;126(4):1079-86
15486367
J Gastrointest Surg. 2008 Oct;12(10):1709-16; discussion 1716
18704600
Am Surg. 2006 Nov;72(11):1038-42; discussion 1061-9, 1133-48
17120945
Ann Surg. 1999 Sep;230(3):404-11; discussion 411-3
10493487
Ann Surg. 2004 May;239(5):722-30; discussion 730-2
15082977
JAMA. 2005 Oct 19;294(15):1909-17
16234497
Surgery. 2009 Aug;146(2):375-80
19628098
J Vasc Surg. 2008 Aug;48(2):355-360; discussion 360-1
18572353
J Gastrointest Surg. 2008 Sep;12(9):1534-9
18612710